Greenleaf Trust Has $1.73 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Greenleaf Trust grew its position in HCA Healthcare, Inc. (NYSE:HCA) by 0.8% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 5,771 shares of the company’s stock after buying an additional 46 shares during the period. Greenleaf Trust’s holdings in HCA Healthcare were worth $1,732,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the stock. FMR LLC grew its stake in shares of HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after purchasing an additional 2,397,883 shares during the period. Franklin Resources Inc. grew its stake in shares of HCA Healthcare by 11.7% during the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock worth $660,842,000 after purchasing an additional 174,946 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of HCA Healthcare by 2.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock worth $604,511,000 after purchasing an additional 41,190 shares during the period. Janus Henderson Group PLC grew its stake in shares of HCA Healthcare by 12.0% during the third quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock worth $544,467,000 after purchasing an additional 143,995 shares during the period. Finally, Nordea Investment Management AB grew its stake in HCA Healthcare by 29.7% in the fourth quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock valued at $253,020,000 after acquiring an additional 193,075 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have issued reports on HCA. Royal Bank of Canada decreased their target price on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. KeyCorp decreased their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Oppenheimer boosted their target price on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. TD Cowen cut their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Finally, Bank of America cut their price target on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

Insider Activity

In other news, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

HCA Healthcare Stock Performance

HCA opened at $330.24 on Monday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The firm has a market capitalization of $83.65 billion, a PE ratio of 15.03, a PEG ratio of 1.12 and a beta of 1.64. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The business’s 50-day simple moving average is $313.33 and its 200 day simple moving average is $353.29.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the business earned $5.90 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.91 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.87%. HCA Healthcare’s dividend payout ratio is currently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.